You are here

BCX4161

4 Key FDA Decisions Expected By Year End

24/7 Wall St

Sun, 11/29/15 - 12:43 pm

Tetraphase Pharmaceuticals

Clovis Oncology

Special FDA designation puts more wind behind BioCryst's sails

Bizjournals.com

Mon, 01/26/15 - 10:01 am

hereditary angiodema

BioCryst Hits Trifecta For Flu, Ebola, and Hereditary Angioedema

Forbes

Fri, 12/26/14 - 10:22 pm

hereditary angiodema

BioCryst's immune disorder drug succeeds in mid-stage trial

Yahoo/Reuters

Tue, 05/27/14 - 09:24 am

hereditary angiodema

BioCryst to Announce Results From the BCX4161 OPuS-1 Phase 2 Trial for Hereditary Angioedema May 27

Yahoo/Globe Newswire

Sun, 05/25/14 - 10:22 am

3 Catalysts Biocryst Investors Need to Watch

Motley Fool

Wed, 10/23/13 - 04:05 pm

BioCryst: The Next Orphan Drug $1B+ Company

Seeking Alpha

Sat, 08/3/13 - 10:27 am